DMK Pharmaceuticals News - DMK

Company Name	Stock Ticker Symbol	Market	Type
DMK Pharmaceuticals Corporation	DMK	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	0.232	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
			0.232	0.232

more quote information »

Recent News

Date	Time	Source	Heading
3/21/2024	14:23	EDGAR2	Form 25-NSE - Notification filed by national security..
2/07/2024	17:19	EDGAR2	Form 8-K - Current report
2/06/2024	10:04	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/05/2024	09:00	EDGAR2	Form 8-K - Current report
1/31/2024	17:17	EDGAR2	Form 8-K - Current report
1/23/2024	17:23	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
1/23/2024	17:22	EDGAR2	Form 8-K - Current report
1/03/2024	17:03	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
1/03/2024	17:02	EDGAR2	Form 8-K - Current report
1/03/2024	17:00	EDGAR2	Form 8-K - Current report
12/21/2023	12:31	EDGAR2	Form 8-K - Current report
12/21/2023	08:15	GLOBE	DMK Pharmaceuticals Regains Full Rights to Commercialize..
12/04/2023	16:47	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
12/04/2023	16:45	EDGAR2	Form 8-K - Current report
11/28/2023	16:41	EDGAR2	Form 8-K - Current report
11/28/2023	08:05	GLOBE	DMK Pharmaceuticals Regains Full Rights from US WorldMeds..
11/15/2023	16:39	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
11/15/2023	16:20	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
11/15/2023	16:11	EDGAR2	Form 8-K - Current report
11/15/2023	16:06	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
11/14/2023	15:57	EDGAR2	Form 8-K - Current report
11/14/2023	07:30	GLOBE	DMK Pharmaceuticals Reports Third Quarter 2023 Financial..
11/13/2023	10:52	GLOBE	DMK Pharmaceuticals Announces Presentation of Preclinical..
11/02/2023	16:50	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/02/2023	16:31	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
10/30/2023	07:30	GLOBE	DMK Pharmaceuticals Announces Inducement Option Grant Under..
10/25/2023	17:18	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/25/2023	17:01	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
10/20/2023	16:15	GLOBE	DMK Pharmaceuticals Announces Inducement Option Grant Under..
10/19/2023	17:07	EDGAR2	Form 8-K - Current report
10/19/2023	16:05	GLOBE	DMK Pharmaceuticals Restructures Executive Team to Support..
10/17/2023	16:37	EDGAR2	Form 8-K - Current report
10/17/2023	12:28	EDGAR2	Form PX14A6G - Notice of exempt solicitation submitted by..
10/12/2023	16:22	EDGAR2	Form DEFC14A - Definitive proxy statement, contested..
10/10/2023	06:01	EDGAR2	Form 8-K - Current report
10/02/2023	16:49	EDGAR2	Form PREC14A - Preliminary proxy statements, contested..
9/26/2023	08:37	EDGAR2	Form SC 13D/A - General statement of acquisition of..
9/19/2023	17:17	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/07/2023	12:00	GLOBE	Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals..